Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue

Submit an article Journal homepage

Open access

103

Views

CrossRef citations to date

Altmetric

Original Research

Inhaled treatment of COPD: a Delphi consensus statement

Vincent Ninane1 Department of Respiratory Medicine, Saint-Pierre Hospital, Université Libre de Bruxelles, BrusselsCorrespondence[email protected]

Jean-Louis Corhay2 Department of Respiratory Medicine, CHU, Liege

Paul Germonpré3 Department of Respiratory Medicine, AZ Maria Middelares, Ghent

Wim Janssens4 Department of Respiratory Medicine, Katholieke Universiteit, Leuven

Guy F Joos5 Department of Respiratory Medicine, Ghent University Hospital, Ghent

Giuseppe Liistro6 Department of Respiratory Medicine, University Hospitals Saint-Luc, Brussels

Walter Vincken7 Department of Respiratory Medicine, University Hospital Brussels, Brussels

Sandra Gurdain8 Medical Department, Novartis Pharma, Vilvoorde, Belgium

Evelyne Vanvlasselaer8 Medical Department, Novartis Pharma, Vilvoorde, Belgium

An Lehouck8 Medical Department, Novartis Pharma, Vilvoorde, Belgium

show all

Pages 793-801 | Published online: 06 Mar 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Global Initiative for Chronic Obstructive Lung Disease (GOLD 2016)Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease [Updated: December, 2015]. Available from: www.goldcopd.orgAccessed May 23, 2016
Google Scholar
JohannessenANilsenRStorebøMComparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalizationAm J Respir Crit Care Med20131881515923590268
PubMed Web of Science ®Google Scholar
WedzichaJCalverleyPSeemungalTHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
PubMed Web of Science ®Google Scholar
LangePMarottJVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
PubMed Web of Science ®Google Scholar
CelliBDecramerMWedzichaJAn Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary diseaseEur Respir J201545487990525829431
PubMed Web of Science ®Google Scholar
FinkAKosecoffJChassinMBrookRHConsensus methods: characteristics and guidelines for useAm J Public Health19847499799836380323
PubMed Web of Science ®Google Scholar
BaumannMStrangeCHeffnerJManagement of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statementChest2001119259060211171742
PubMed Web of Science ®Google Scholar
PavordIAgustiABlood eosinophil count: a biomarker of an important treatable trait in patients with airway diseaseEur Respir J20164751299130327132257
PubMed Web of Science ®Google Scholar
BarrRGBourbeauJCamargoCARamFSInhaled tiotropium for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20052CD002876
Google Scholar
AppletonSJonesTPoolePIpratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20063CD006101
Google Scholar
PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171997297715665324
PubMed Web of Science ®Google Scholar
PerezTBurgelPPaillasseurJModified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101663167226316740
PubMed Web of Science ®Google Scholar
JonesPAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationEur Respir J201342364765423258783
PubMed Web of Science ®Google Scholar
WoodruffPBarrRBleeckerEClinical significance of symptoms in smokers with preserved pulmonary functionN Engl J Med2016374191811182127168432
PubMed Web of Science ®Google Scholar
DecramerMCelliBKestenSEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
PubMed Web of Science ®Google Scholar
TroostersTCelliBLystigTTiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trialEur Respir J2010361657320185426
PubMed Web of Science ®Google Scholar
VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
PubMed Web of Science ®Google Scholar
DecramerMChapmanKDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
PubMed Web of Science ®Google Scholar
ZhongNWangCZhouXLANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPDInt J Chron Obstruct Pulmon Dis2015101015102626082625
PubMed Web of Science ®Google Scholar
VogelmeierCBatemanEPallanteJEfficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyLancet Respir Med201311516024321804
PubMed Web of Science ®Google Scholar
WedzichaJBanerjiDChapmanKRIndacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPDN Engl J Med2016374232222223427181606
PubMed Web of Science ®Google Scholar
ErnstPSaadNSuissaSInhaled corticosteroids in COPD: the clinical evidenceEur Respir J201545252553725537556
PubMed Web of Science ®Google Scholar
CorradoARossiAHow far is real life from COPD therapy guidelines? An Italian observational studyRespir Med2012106798999722483189
PubMed Web of Science ®Google Scholar
RocheNPribilCVan GanseEReal-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational studyBMC Pulm Med2014145624694050
PubMed Web of Science ®Google Scholar
MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med20143711285129425196117
PubMed Web of Science ®Google Scholar
HassonFKeeneySMcKennaHResearch guidelines for the Delphi survey techniqueJ Adv Nurs20003241008101511095242
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Inhaled treatment of COPD: a Delphi consensus statement

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Inhaled treatment of COPD: a Delphi consensus statement

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date